Witness Dr Bruce Carruthers -NICE guideline JR

[Guest guest]

Dr Bruce M. Carruthers (see below) belongs

together with Anil Kumar Jain, Kenny L. De Meirleir,

L. , G. Klimas, A.

Lerner, Alison C. Bested, Pierre Flor-Henry, Pradip

Joshi, A. C. Powles, A. Sherkey, and

Marjorie I. van de Sande to the authors of the best

ever written ME/CFS case definition:

Myalgic Encephalomyelitis/ Chronic Fatigue

Syndrome: Clinical Working Case Definition,

Diagnostic and Treatment Protocols. (2003)

This systematic clinical working case definition is

drafted by *Health Canada* order.

This definition encourages a diagnosis, based on

characteristic patterns of symptom clusters, which

reflect specific areas of pathogenesis. (Diagnostic

and treatment protocols, and a short overview of

research are given to facilitate a comprehensive and

integrated approach to this illness).

This guideline can be found on the the website of

the of the ME Society of America:

http://www.cfids-cab.org/MESA/ccpccd.pdf

For private members this definition is, together with

the Witness Statement of Dr Bruce Carruthers versus

the NICE guideline Judicial Review ( Fraser

and Short) attached as pdf documents.

~jvr

````

From: contact@...

Via: CO-CURE

WITNESS STATEMENT OF DR

BRUCE CARRUTHERS FOR

FRASER & SHORT V NICE.

Dear All,

In his witness statement provided for Fraser

and Short for the UK High Court Judicial Review

of the NICE 'CFS/ME' Guideline (CG53) Dr Bruce

Carruthers, lead author of the International

('Canadian') ME Diagnostic & Treatment Protocols

thoroughly dissects, assesses and then condemns

the Guideline.

In conclusion he unequivocally states the

following:

" The NICE document does not aid the clinician by

offering guidance about the defining

symptomatology of ME/CFS as an aid to diagnosis

and treatment: all it does is to offer a cook-book

diagnostic process that must be followed, and

then it recommends two non-specific behavioural

approaches that are not treatment-based and

which are non-specific to the disorder under

review.

Overall, the process and the resulting Guideline

are, in my opinion, detrimental to both patients'

best interests and to best clinical practice.

The present Guideline cannot by any standards be

considered as providing " best practice advice on

the care of people with CFS/ME " nor is it " based

on the best available evidence " as it claims.

In my opinion it should be withdrawn. "

Such outright international condemnation from

someone of Dr Carruthers' professional standing and

experience ought to ring alarm bells in any

right-minded person. Dr Carruthers' full witness

statement for Fraser & Short is now published with

his permission. It is available now as a .pdf

download at the web addresses below.

Best wishes,

Short.

contact@...

http://www.angliameaction.org.uk/NICEJRdocs/Bruce_Carruthers_WS.pdf

http://www.meactionuk.org.uk/Bruce_Carruthers_WS.pdf